Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parent-to-Child Nasal Microbiome Transplant in Neonates
NCT06283355Phase 1Active, not recruiting
- Sponsor
- Johns Hopkins University
- Start
- Sep 2024
- Primary completion
- Apr 2026
- Countries
- 1
01
Overview
Phase 1, randomised trial in Staphylococcus aureus colonization and neonatal infection (3 arms), sponsored by Johns Hopkins University. Primary endpoint: Neonatal nasal microbiome diversity at 14 days. Started Sep 2024; status: active, not recruiting.
02
Conditions
Staphylococcus aureus colonizationneonatal infection
Beyond the preview
Go deeper on NCT06283355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06283355.